165 related articles for article (PubMed ID: 37759159)
1. Hypersensitive C-reactive protein as a potential indicator for predicting left ventricular hypertrophy in elderly community-dwelling patients with hypertension.
Song W; Zhang C; Tang J; Li Y; Jiao T; Lin X; Wang Y; Fang J; Sha J; Ding T; Cheng J; Li J
BMC Cardiovasc Disord; 2023 Sep; 23(1):480. PubMed ID: 37759159
[TBL] [Abstract][Full Text] [Related]
2. High-sensitivity C-reactive protein: an independent risk factor for left ventricular hypertrophy in patients with lupus nephritis.
Shi B; Ni Z; Cai H; Zhang M; Mou S; Wang Q; Cao L; Yu Z; Yan Y; Qian J
J Biomed Biotechnol; 2010; 2010():373426. PubMed ID: 21076530
[TBL] [Abstract][Full Text] [Related]
3. Hypertension, fluid overload and micro inflammation are associated with left ventricular hypertrophy in maintenance hemodialysis patients.
Xu Y; Chen Y; Li D; Li J; Liu X; Cui C; Yu C
Ren Fail; 2013 Oct; 35(9):1204-9. PubMed ID: 23901794
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram.
Nardi E; Palermo A; Mulè G; Cusimano P; Cerasola G; Rini GB
Eur J Prev Cardiol; 2013 Oct; 20(5):854-61. PubMed ID: 22556375
[TBL] [Abstract][Full Text] [Related]
5. Association of left ventricular hypertrophy with high-sensitive C-reactive protein in hemodialysis patients.
Monfared A; Salari A; Kazemnezhad E; Lebadi M; Khosravi M; Mehrjardi NK; Rahimifar S; Amini N
Int Urol Nephrol; 2013 Dec; 45(6):1679-86. PubMed ID: 23306861
[TBL] [Abstract][Full Text] [Related]
6. Association between red blood cell distribution width and left ventricular hypertrophy in pediatric essential hypertension.
Sun X; Liu Y; Liu Y; Wang H; Liu B; Shi L
Front Pediatr; 2023; 11():1088535. PubMed ID: 36816384
[TBL] [Abstract][Full Text] [Related]
7. C-reactive protein, left ventricular mass index, and risk of cardiovascular disease in essential hypertension.
Iwashima Y; Horio T; Kamide K; Rakugi H; Ogihara T; Kawano Y
Hypertens Res; 2007 Dec; 30(12):1177-85. PubMed ID: 18344622
[TBL] [Abstract][Full Text] [Related]
8. [Clinical features and risk factors of left ventricular hypertrophy in children with primary hypertension].
Liu Y; Shi L; Lin Y; Li YQ; Liu YY; Zhang HW
Zhonghua Er Ke Za Zhi; 2023 Nov; 61(11):1031-1037. PubMed ID: 37899343
[No Abstract] [Full Text] [Related]
9. NLR-A Simple Indicator of Inflammation for the Diagnosis of Left Ventricular Hypertrophy in Patients with Hypertension.
Yu X; Xue Y; Bian B; Wu X; Wang Z; Huang J; Huang L; Sun Y
Int Heart J; 2020 Mar; 61(2):373-379. PubMed ID: 32173694
[TBL] [Abstract][Full Text] [Related]
10. Association between high-sensitivity troponin T, left ventricular hypertrophy, and myocardial performance index.
Kaypakli O; Gür M; Gözükara MY; Uçar H; Kivrak A; Şeker T; Şahin DY; Elbasan Z; Türkoğlu C; Çayli M
Herz; 2015 Nov; 40(7):1004-10. PubMed ID: 26087700
[TBL] [Abstract][Full Text] [Related]
11. Association of tumor necrosis factor-alpha with early target organ damage in newly diagnosed patients with essential hypertension.
Navarro-González JF; Mora C; Muros M; Jarque A; Herrera H; García J
J Hypertens; 2008 Nov; 26(11):2168-75. PubMed ID: 18854757
[TBL] [Abstract][Full Text] [Related]
12. What Is the Effect of Metabolic Syndrome without Hypertension on Left Ventricular Hypertrophy?
Al-Daydamony MM; El-Tahlawi M
Echocardiography; 2016 Sep; 33(9):1284-9. PubMed ID: 27109543
[TBL] [Abstract][Full Text] [Related]
13. The Diagnostic Value of the Deepest S Wave in 12-Lead Electrocardiogram to Elderly Patients with Essential Hypertension and Left Ventricular Hypertrophy.
Ji D; Zhang B; He B
Clin Interv Aging; 2022; 17():1663-1672. PubMed ID: 36444336
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of left ventricular hypertrophy associated with type-2 diabetes in Shiraz, Iran: a cross-sectional study.
Parsa N; Moheb M; Zibaeenezhad MJ; Karimi-Akhormeh A; Trevisan M; Wallin L; Zaheri PM; Sayadi M; Razeghian-Jahromi I; Moaref A
BMC Cardiovasc Disord; 2023 Feb; 23(1):88. PubMed ID: 36792995
[TBL] [Abstract][Full Text] [Related]
15. Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy.
Yasunari K; Maeda K; Watanabe T; Nakamura M; Yoshikawa J; Asada A
J Am Coll Cardiol; 2004 Jun; 43(11):2116-23. PubMed ID: 15172423
[TBL] [Abstract][Full Text] [Related]
16. C-reactive protein and incident left ventricular hypertrophy in essential hypertension.
Assadi F
Pediatr Cardiol; 2007; 28(4):280-5. PubMed ID: 17563829
[TBL] [Abstract][Full Text] [Related]
17. Relationship of a new anthropometric index with left ventricular hypertrophy in hypertensive patients among the Han Chinese.
Cai S; Dong J; Cheng B; Zhang A; Sun J; Li M; Su Y; Bao Q; Zhu P; Wang S
BMC Cardiovasc Disord; 2022 Jan; 22(1):16. PubMed ID: 35081909
[TBL] [Abstract][Full Text] [Related]
18. Microalbuminuria and left ventricular hypertrophy among newly diagnosed black African hypertensive patients: a cross sectional study from a tertiary hospital in Uganda.
Nabbaale J; Kibirige D; Ssekasanvu E; Sebatta ES; Kayima J; Lwabi P; Kalyesubula R
BMC Res Notes; 2015 May; 8():198. PubMed ID: 25971452
[TBL] [Abstract][Full Text] [Related]
19. Relation of left ventricular hypertrophy to microalbuminuria and C-reactive protein in children and adolescents with essential hypertension.
Assadi F
Pediatr Cardiol; 2008 May; 29(3):580-4. PubMed ID: 18046596
[TBL] [Abstract][Full Text] [Related]
20. Persistent elevation of C-reactive protein may predict cardiac hypertrophy and dysfunction in patients maintained on hemodialysis.
Kim BS; Jeon DS; Shin MJ; Kim YO; Song HC; Lee SH; Kim SY; Choi EJ; Chang YS; Bang BK
Am J Nephrol; 2005; 25(3):189-95. PubMed ID: 15863980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
